Select Equity Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555M Sell
1,981,948
-192,837
-9% -$50.7M 2.74% 8
2026
Q1
$580M Buy
2,174,785
+64,006
+3% +$17.3M 2.97% 9
2025
Q4
$530M Buy
2,110,779
+273,744
+15% +$72.7M 2.28% 14
2025
Q3
$527M Sell
1,837,035
-295,757
-14% -$79.2M 2.17% 17
2025
Q2
$560M Sell
2,132,792
-87,264
-4% -$21.2M 2.35% 18
2025
Q1
$517M Buy
2,220,056
+624,099
+39% +$151M 2.23% 16
2024
Q4
$366M Buy
1,595,957
+959,981
+151% +$220M 1.45% 28
2024
Q3
$142M Buy
635,976
+272,711
+75% +$59.9M 0.51% 53
2024
Q2
$73.9M Buy
+363,265
New +$73.9M 0.29% 66

Other funds holding LH

Select Equity Group's LH Position: Q2 2026 in Review

Select Equity Group reduced its Labcorp (LH) stake by 8.9% in Q2 2026, selling an estimated $50.7M and leaving 1,981,948 shares worth $555M. The position accounts for 2.74% of the portfolio, ranked #8.

Select Equity Group first reported a position in LH in Q2 2024 and has held it in 9 quarters since. The position peaked at $580M in Q1 2026. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Select Equity Group held 1,981,948 shares of Labcorp worth $555M as of Q2 2026.
  • Select Equity Group sold 192,837 Labcorp shares in Q2 2026, an estimated $50.7M.
  • Labcorp made up 2.74% of Select Equity Group's portfolio in Q2 2026, its #8 holding.
  • Select Equity Group first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • Select Equity Group's Labcorp position peaked at $580M in Q1 2026.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Select Equity Group's 13F filing for Q2 2026, filed 14 Aug 2026.